A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies

Celebrity F. Groenendijk; Marta Rovituso; Danny Lathouwers; Jeremy M.C. Brown

doi:10.1016/j.ejmp.2023.102643

A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies

Celebrity F. Groenendijk, Marta Rovituso, Danny Lathouwers, Jeremy M.C. Brown^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Scientific › peer-review

1 Citation (Scopus)

55 Downloads (Pure)

Abstract

A Geant4 based simulation platform of the Holland Proton Therapy Centre (HollandPTC, Netherlands) R&D beamline (G4HPTC-R&D) was developed to enable the planning, optimisation and advanced dosimetry for radiobiological studies. It implemented a six parameter non-symmetrical Gaussian pencil beam surrogate model to simulate the R&D beamline in both a pencil beam and passively scattered field configuration. Three different experimental proton datasets (70 MeV, 150 MeV, and 240 MeV) of the pencil beam envelope evolution in free air and depth-dose profiles in water were used to develop a set of individual parameter surrogate functions to enable the modelling of the non-symmetrical Gaussian pencil beam properties with only the ProBeam isochronous cyclotron mean extraction proton energy as input. This refined beam model was then benchmarked with respect to three independent experimental datasets of the R&D beamline operating in both a pencil beam configuration at 120 and 200 MeV, and passively scattered field configuration at 150 MeV. It was shown that the G4HPTC-R&D simulation platform can reproduce the pencil beam envelope evolution in free air and depth-dose profiles to within an accuracy on the order of ±5% for all tested energies, and that it was able to reproduce the 150 MeV passively scattered field to the specifications need for clinical and radiobiological applications.

Original language	English
Article number	102643
Number of pages	8
Journal	Physica Medica
Volume	112
DOIs	https://doi.org/10.1016/j.ejmp.2023.102643
Publication status	Published - 2023

Keywords

Geant4
HollandPTC
Proton radiotherapy
Radiobiology
Radiotherapy

Access to Document

10.1016/j.ejmp.2023.102643

1-s2.0-S1120179723001205-mainFinal published version, 2.05 MBLicence: CC BY

Cite this

@article{e5ef335654be41269bb29602dd281757,

title = "A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies",

abstract = "A Geant4 based simulation platform of the Holland Proton Therapy Centre (HollandPTC, Netherlands) R&D beamline (G4HPTC-R&D) was developed to enable the planning, optimisation and advanced dosimetry for radiobiological studies. It implemented a six parameter non-symmetrical Gaussian pencil beam surrogate model to simulate the R&D beamline in both a pencil beam and passively scattered field configuration. Three different experimental proton datasets (70 MeV, 150 MeV, and 240 MeV) of the pencil beam envelope evolution in free air and depth-dose profiles in water were used to develop a set of individual parameter surrogate functions to enable the modelling of the non-symmetrical Gaussian pencil beam properties with only the ProBeam isochronous cyclotron mean extraction proton energy as input. This refined beam model was then benchmarked with respect to three independent experimental datasets of the R&D beamline operating in both a pencil beam configuration at 120 and 200 MeV, and passively scattered field configuration at 150 MeV. It was shown that the G4HPTC-R&D simulation platform can reproduce the pencil beam envelope evolution in free air and depth-dose profiles to within an accuracy on the order of ±5% for all tested energies, and that it was able to reproduce the 150 MeV passively scattered field to the specifications need for clinical and radiobiological applications.",

keywords = "Geant4, HollandPTC, Proton radiotherapy, Radiobiology, Radiotherapy",

author = "Groenendijk, {Celebrity F.} and Marta Rovituso and Danny Lathouwers and Brown, {Jeremy M.C.}",

year = "2023",

doi = "10.1016/j.ejmp.2023.102643",

language = "English",

volume = "112",

journal = "Physica Medica",

issn = "1120-1797",

publisher = "Associazione Italiana di Fisica Medica",

}

TY - JOUR

T1 - A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies

AU - Groenendijk, Celebrity F.

AU - Rovituso, Marta

AU - Lathouwers, Danny

AU - Brown, Jeremy M.C.

PY - 2023

Y1 - 2023

N2 - A Geant4 based simulation platform of the Holland Proton Therapy Centre (HollandPTC, Netherlands) R&D beamline (G4HPTC-R&D) was developed to enable the planning, optimisation and advanced dosimetry for radiobiological studies. It implemented a six parameter non-symmetrical Gaussian pencil beam surrogate model to simulate the R&D beamline in both a pencil beam and passively scattered field configuration. Three different experimental proton datasets (70 MeV, 150 MeV, and 240 MeV) of the pencil beam envelope evolution in free air and depth-dose profiles in water were used to develop a set of individual parameter surrogate functions to enable the modelling of the non-symmetrical Gaussian pencil beam properties with only the ProBeam isochronous cyclotron mean extraction proton energy as input. This refined beam model was then benchmarked with respect to three independent experimental datasets of the R&D beamline operating in both a pencil beam configuration at 120 and 200 MeV, and passively scattered field configuration at 150 MeV. It was shown that the G4HPTC-R&D simulation platform can reproduce the pencil beam envelope evolution in free air and depth-dose profiles to within an accuracy on the order of ±5% for all tested energies, and that it was able to reproduce the 150 MeV passively scattered field to the specifications need for clinical and radiobiological applications.

AB - A Geant4 based simulation platform of the Holland Proton Therapy Centre (HollandPTC, Netherlands) R&D beamline (G4HPTC-R&D) was developed to enable the planning, optimisation and advanced dosimetry for radiobiological studies. It implemented a six parameter non-symmetrical Gaussian pencil beam surrogate model to simulate the R&D beamline in both a pencil beam and passively scattered field configuration. Three different experimental proton datasets (70 MeV, 150 MeV, and 240 MeV) of the pencil beam envelope evolution in free air and depth-dose profiles in water were used to develop a set of individual parameter surrogate functions to enable the modelling of the non-symmetrical Gaussian pencil beam properties with only the ProBeam isochronous cyclotron mean extraction proton energy as input. This refined beam model was then benchmarked with respect to three independent experimental datasets of the R&D beamline operating in both a pencil beam configuration at 120 and 200 MeV, and passively scattered field configuration at 150 MeV. It was shown that the G4HPTC-R&D simulation platform can reproduce the pencil beam envelope evolution in free air and depth-dose profiles to within an accuracy on the order of ±5% for all tested energies, and that it was able to reproduce the 150 MeV passively scattered field to the specifications need for clinical and radiobiological applications.

KW - Geant4

KW - HollandPTC

KW - Proton radiotherapy

KW - Radiobiology

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85166240349&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2023.102643

DO - 10.1016/j.ejmp.2023.102643

M3 - Article

AN - SCOPUS:85166240349

SN - 1120-1797

VL - 112

JO - Physica Medica

JF - Physica Medica

M1 - 102643

ER -

A Geant4 based simulation platform of the HollandPTC R&D proton beamline for radiobiological studies

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this